Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 5/20 | 0.43 |
| ▸ | HTR7 | P34969 | 2/20 | 0.43 |
| ▸ | METAP1 | P53582 | 2/20 | 0.41 |
| ▸ | HTR2A | P28223 | 3/20 | 0.40 |
| ▸ | HTR2C | P28335 | 3/20 | 0.40 |
| ▸ | DRD2 | P14416 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | HTR2B | P41595 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7714801 | 0.87 | CYP2A6 (0.43) | CYP2A6MAOAMAOBSIGMAR1ACHE | |
| SCHEMBL7714698 | 0.87 | HTR7 (0.52) | CYP2A6MAOAMAOBSIGMAR1ACHE | |
| SCHEMBL599314 | 0.78 | CYP19A1 (0.54) | MAOAMAOBSIGMAR1CYP19A1 | |
| SCHEMBL27342980 | 0.75 | SIGMAR1 (0.50) | CYP2A6MAOAMAOBSIGMAR1ACHE | |
| SCHEMBL30393799 | 0.73 | LMNA (0.39) | MAOAACHE | |
| SCHEMBL7714800 | 0.73 | CYP2A6 (0.46) | CYP2A6MAOAMAOBSIGMAR1ACHE | |
| SCHEMBL183347 | 0.73 | LMNA (0.39) | MAOAACHE | |
| SCHEMBL28591575 | 0.73 | ACHE (0.47) | MAOASIGMAR1ACHETSHR | |
| Anthraquinone SCHEMBL28278072 | 0.72 | LMNA (0.41) | MAOATSHR | |
| SCHEMBL6113050 | 0.72 | CYP2A6 (0.44) | CYP2A6MAOAMAOBACHEHTR7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6369110-B1 | PROPHYLACTIC AGENT FOR DISEASES CAUSED BY THE ACCELERATION OF THE SODIUM/PROTON EXCHANGE TRANSPORT SYSTEM | SUMITOMO PHARMACEUTICALS COMPANY (JP) | 2002-04-09 | — | — | US | disclosed |
| EP-1083166-A1 | NOVEL SUBSTITUTED GUANIDINE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 2001-03-14 | — | — | EP | disclosed |